Patent application number | Description | Published |
20090284067 | VEHICLE OCCUPANT RESTRAINT BELT SYSTEM - A 4-point occupant restraint belt system for a vehicle seat having a seat bottom and a back rest. A one-piece belt is connected to the vehicle at upper and lower attachment points disposed adjacent a first side of the vehicle seat, and a buckle is disposed adjacent an opposite second side of the vehicle seat. A latch is slidingly mounted on the belt and engagable with the buckle to secure the belt around a seat occupant in a three-point configuration. A lifting arm has a lowered position wherein it is beneath the belt and adjacent the latch when the latch is engaged with the buckle, and the lifting arm is movable to a raised position wherein it raises a portion of the belt to a position adjacent the back rest above the buckle, thereby creating a 4 | 11-19-2009 |
20120256404 | Method and control device for the activation of a passenger safety arrangement of a vehicle - A method of activating a passenger safety arrangement of a vehicle, the method including reading in a roll rate of the vehicle and triggering the passenger safety arrangement when, at a first time, at least one roll rate value is present, which exhibits a positive sign and is larger than a roll rate positive threshold value and when, at a second time after the first time, at least one roll rate value is present, which exhibits a negative sign and is smaller than a roll rate negative threshold value. | 10-11-2012 |
20140350796 | METHOD AND SYSTEM OF A VEHICLE FOR REVERSIBLE SEAT BELT RETRACTION - A method performed by a retraction control system of a vehicle for controlling refraction of a seat belt of a reversible seat belt refractor arrangement for a vehicle occupant is provided. The control system determines fulfillment of an activation condition based on an initiating input derived from a vehicle situation sensing system, which initiating input indicates that the vehicle, at an initiating time instant, is considered likely to be, or is about to become, involved in a hazardous situation and/or uncomfortable dynamic situation. The control system generates an activation signal utilizable for initiation of retraction of the seat belt. If the control system determines absence of fulfillment of a confirming condition within a predetermined confirming time period, and/or if the control system determines fulfillment of an abort condition within a predetermined abort time period, the control system generates a deactivation signal utilizable for aborting the initiation. | 11-27-2014 |
Patent application number | Description | Published |
20130025540 | MILKING SYSTEM AND METHOD FOR ANALYZING MILK - A milking system includes a milk storage tank, a common milk line connected to the tank, at least two milking stations connected to the milk line, a milk constituent analyzing unit connected to the milk line and analyzing the milk provided from each of the stations through the milk line, with respect to a specific milk constituent, and a computer operatively connected to the analyzing unit. The computer stores milk quality information of the extracted milk and animal identity data of each of the specifically identified animals. Each station automatically identifies a specific animal, extracts milk from the animal, and transfers the milk through the common milk line to the milk storage tank. The stations, the computer, and the analyzing unit are operatively connected to allow a result of the milk analysis to be associated with the animal(s) identity specifically identified at each station from which the milk was extracted. | 01-31-2013 |
20130025541 | ARRANGEMENT AND METHOD FOR ANALYZING MILK - A milk analyzing system is disclosed, which includes a milk constituent analyzing unit configured to analyze milk from a milking station with respect to a specific constituent of the milk, and a control device communicatively connected to the milking station and to the milk constituent analyzing unit. The control device is configured to retrieve an analyzing appropriateness parameter for each of the animals milked by the milking station indicating an appropriateness of analyzing milk from the animal with respect to the specific constituent. The control device is configured to control the milk constituent analyzing unit to analyze milk from the milking station with respect to the specific constituent when the time elapsed from when the milk constituent analyzing unit last analyzed milk exceeds a threshold time period, irrespective of the analyzing appropriateness parameter for the animal milked by the milking station. | 01-31-2013 |
20140158065 | DEVICE TO MOTIVATE AN ANIMAL TO LEAVE A MILKING STALL - A device to motivate an animal to leave a milking stall includes at least a first unit configured to motivate the animal to leave the milking stall by a first motivation means; a second unit configured to motivate the animal to leave the milking stall by a second motivation means which is of a different type than the first motivation means; and a control unit configured, when it is time for the animal to leave the milking stall, to activate at least one of the first and second units such that the animal in the milking stall will be motivated to leave the milking stall. | 06-12-2014 |
Patent application number | Description | Published |
20080221207 | USE OF SPECIFIC CYKLOLIGNANS - The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9′ have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, atherosclerosis and acromegaly. A preferred compound is picropodophyllin. | 09-11-2008 |
20090326248 | USE OF SPECIFIC CYKLOLIGNANS - The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9′ have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin. | 12-31-2009 |
20100216728 | NEW USE OF SPECIFIC CYKLOLIGNANS - The invention refers to the use of specific cyclolignans, wherein the carbon atoms in positions 9 and 9′ have cis configuration, for inhibition of the insulin-like growth factor-1 receptor. Said compounds can be used for treatment of IGF-1R dependent diseases, such as cancer, psoriasis, artherosclerosis and acromegaly. A preferred compound is picropodophyllin. | 08-26-2010 |
20100227797 | USE OF CYCLOLIGNANS FOR THE TREATMENT OF TYPE 2 DIABETES AND AS CONTRACEPTIVES - There is disclosed use of certain cyclolignans for prophylaxis or treatment of diabetes mellitus type 2, nephropathy, retinopathy, macular degeneration, retinopathy of prematurity, central retinal vein occlusion, branch retinal vein occlusion, rubeotic glaucoma, thyroid eye disease, corneal graft rejection and corneal chemical burns; and for contraception. Preferred compounds are picropodophyllin, deoxypicropodophyllin and anhydropicropodophyllol. There is also described a method of treatment of an eye disease. | 09-09-2010 |